Global Oral Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Oral Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
According to APO Research, The global Oral Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Oral Vaccines include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Oral Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Oral Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Oral Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Oral Vaccines sales, projected growth trends, production technology, application and end-user industry.

Oral Vaccines segment by Company

Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Oral Vaccines segment by Type

Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Oral Vaccines segment by Application

Public
Private
Oral Vaccines segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Oral Vaccines Market Size, 2019 VS 2023 VS 2030
1.3 Global Oral Vaccines Market Size Estimates and Forecasts (2019-2030)
1.4 Global Oral Vaccines Sales Estimates and Forecasts (2019-2030)
1.5 Global Oral Vaccines Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Oral Vaccines Market Dynamics
2.1 Oral Vaccines Industry Trends
2.2 Oral Vaccines Industry Drivers
2.3 Oral Vaccines Industry Opportunities and Challenges
2.4 Oral Vaccines Industry Restraints
3 Oral Vaccines Market by Manufacturers
3.1 Global Oral Vaccines Revenue by Manufacturers (2019-2024)
3.2 Global Oral Vaccines Sales by Manufacturers (2019-2024)
3.3 Global Oral Vaccines Average Sales Price by Manufacturers (2019-2024)
3.4 Global Oral Vaccines Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Oral Vaccines Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Oral Vaccines Manufacturers, Product Type & Application
3.7 Global Oral Vaccines Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Oral Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2023
3.8.3 2023 Oral Vaccines Tier 1, Tier 2, and Tier 3
4 Oral Vaccines Market by Type
4.1 Oral Vaccines Type Introduction
4.1.1 Rotavirus Vaccine
4.1.2 Cholera Vaccine
4.1.3 Oral Polio Vaccine
4.2 Global Oral Vaccines Sales by Type
4.2.1 Global Oral Vaccines Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Oral Vaccines Sales by Type (2019-2030)
4.2.3 Global Oral Vaccines Sales Market Share by Type (2019-2030)
4.3 Global Oral Vaccines Revenue by Type
4.3.1 Global Oral Vaccines Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Oral Vaccines Revenue by Type (2019-2030)
4.3.3 Global Oral Vaccines Revenue Market Share by Type (2019-2030)
5 Oral Vaccines Market by Application
5.1 Oral Vaccines Application Introduction
5.1.1 Public
5.1.2 Private
5.2 Global Oral Vaccines Sales by Application
5.2.1 Global Oral Vaccines Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Oral Vaccines Sales by Application (2019-2030)
5.2.3 Global Oral Vaccines Sales Market Share by Application (2019-2030)
5.3 Global Oral Vaccines Revenue by Application
5.3.1 Global Oral Vaccines Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Oral Vaccines Revenue by Application (2019-2030)
5.3.3 Global Oral Vaccines Revenue Market Share by Application (2019-2030)
6 Global Oral Vaccines Sales by Region
6.1 Global Oral Vaccines Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Oral Vaccines Sales by Region (2019-2030)
6.2.1 Global Oral Vaccines Sales by Region (2019-2024)
6.2.2 Global Oral Vaccines Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Oral Vaccines Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Oral Vaccines Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Oral Vaccines Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Oral Vaccines Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Oral Vaccines Revenue by Region
7.1 Global Oral Vaccines Revenue by Region
7.1.1 Global Oral Vaccines Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Oral Vaccines Revenue by Region (2019-2024)
7.1.3 Global Oral Vaccines Revenue by Region (2025-2030)
7.1.4 Global Oral Vaccines Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Oral Vaccines Revenue (2019-2030)
7.2.2 North America Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Oral Vaccines Revenue (2019-2030)
7.3.2 Europe Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Oral Vaccines Revenue (2019-2030)
7.4.2 Asia-Pacific Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Oral Vaccines Revenue (2019-2030)
7.5.2 LAMEA Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Merck Oral Vaccines Product Portfolio
8.1.5 Merck Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 GSK Oral Vaccines Product Portfolio
8.2.5 GSK Recent Developments
8.3 Sanofi
8.3.1 Sanofi Comapny Information
8.3.2 Sanofi Business Overview
8.3.3 Sanofi Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Sanofi Oral Vaccines Product Portfolio
8.3.5 Sanofi Recent Developments
8.4 Lanzhou Institute
8.4.1 Lanzhou Institute Comapny Information
8.4.2 Lanzhou Institute Business Overview
8.4.3 Lanzhou Institute Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
8.4.5 Lanzhou Institute Recent Developments
8.5 Serum Institute
8.5.1 Serum Institute Comapny Information
8.5.2 Serum Institute Business Overview
8.5.3 Serum Institute Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Serum Institute Oral Vaccines Product Portfolio
8.5.5 Serum Institute Recent Developments
8.6 Valneva
8.6.1 Valneva Comapny Information
8.6.2 Valneva Business Overview
8.6.3 Valneva Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Valneva Oral Vaccines Product Portfolio
8.6.5 Valneva Recent Developments
8.7 Shanghai United Cell
8.7.1 Shanghai United Cell Comapny Information
8.7.2 Shanghai United Cell Business Overview
8.7.3 Shanghai United Cell Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Shanghai United Cell Oral Vaccines Product Portfolio
8.7.5 Shanghai United Cell Recent Developments
8.8 Bibcol
8.8.1 Bibcol Comapny Information
8.8.2 Bibcol Business Overview
8.8.3 Bibcol Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Bibcol Oral Vaccines Product Portfolio
8.8.5 Bibcol Recent Developments
8.9 PaxVax
8.9.1 PaxVax Comapny Information
8.9.2 PaxVax Business Overview
8.9.3 PaxVax Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 PaxVax Oral Vaccines Product Portfolio
8.9.5 PaxVax Recent Developments
8.10 Vabiotech
8.10.1 Vabiotech Comapny Information
8.10.2 Vabiotech Business Overview
8.10.3 Vabiotech Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Vabiotech Oral Vaccines Product Portfolio
8.10.5 Vabiotech Recent Developments
8.11 Tiantan Biological
8.11.1 Tiantan Biological Comapny Information
8.11.2 Tiantan Biological Business Overview
8.11.3 Tiantan Biological Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Tiantan Biological Oral Vaccines Product Portfolio
8.11.5 Tiantan Biological Recent Developments
8.12 EuBiologics
8.12.1 EuBiologics Comapny Information
8.12.2 EuBiologics Business Overview
8.12.3 EuBiologics Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 EuBiologics Oral Vaccines Product Portfolio
8.12.5 EuBiologics Recent Developments
8.13 Panacea Biotec Ltd
8.13.1 Panacea Biotec Ltd Comapny Information
8.13.2 Panacea Biotec Ltd Business Overview
8.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
8.13.5 Panacea Biotec Ltd Recent Developments
8.14 Bio-Med
8.14.1 Bio-Med Comapny Information
8.14.2 Bio-Med Business Overview
8.14.3 Bio-Med Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 Bio-Med Oral Vaccines Product Portfolio
8.14.5 Bio-Med Recent Developments
8.15 Halfkin Bio-Pharmaceuticals
8.15.1 Halfkin Bio-Pharmaceuticals Comapny Information
8.15.2 Halfkin Bio-Pharmaceuticals Business Overview
8.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
8.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Oral Vaccines Value Chain Analysis
9.1.1 Oral Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Oral Vaccines Production Mode & Process
9.2 Oral Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Oral Vaccines Distributors
9.2.3 Oral Vaccines Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings